Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family

被引:33
作者
Cases, M
García-Serna, R
Hettne, K
Weeber, M
van der Lei, J
Boyer, S
Mestres, J
机构
[1] Inst Municipal Invest Med, Res Unit Biomed Informat, Chemogenom Lab, Barcelona 08003, Catalonia, Spain
[2] Univ Pompeu Fabra, Barcelona 08003, Catalonia, Spain
[3] AstraZeneca R&D, Safety Assessment, S-43183 Molndal, Sweden
[4] Erasmus Univ, Med Ctr, Dept Med Informat, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.2174/1568026054637665
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Nuclear receptors form a family of ligand-activated transcription factors that regulate a wide variety of biological processes and are thus generally considered relevant targets in drug discovery. We have constructed an annotated compound library directed to nuclear receptors (NRacl) as a means for integrating the chemical and biological data being generated within this family. Special care has been put in the appropriate storage of annotations by using hierarchical classification schemes for both molecules and nuclear receptors, which takes the ability to extract knowledge from annotated compound libraries to another level. Analysis of NRacl has ultimately led to the identification of scaffolds with highly promiscuous nuclear receptor profiles and to the classification of nuclear receptor groups with similar scaffold promiscuity patterns. This information can be exploited in the design of probing libraries for deorphanization activities as well as for devising screening batteries to address selectivity issues.
引用
收藏
页码:763 / 772
页数:10
相关论文
共 31 条
[1]  
[Anonymous], CHEMOINFORMATICS DRU
[2]  
Auwerx J, 1999, CELL, V97, P161
[3]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[4]   Hit and lead generation:: Beyond high-throughput screening [J].
Bleicher, KH ;
Böhm, HJ ;
Müller, K ;
Alanine, AI .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :369-378
[5]   Chemogenomics: An emerging strategy for rapid target and drug discovery [J].
Bredel, M ;
Jacoby, E .
NATURE REVIEWS GENETICS, 2004, 5 (04) :262-275
[6]  
*DERW INF LTD, THOMS DERW WORLD DRU
[7]   Nuclear receptors and the control of metabolism [J].
Francis, GA ;
Fayard, E ;
Picard, F ;
Auwerx, J .
ANNUAL REVIEW OF PHYSIOLOGY, 2003, 65 :261-311
[8]   Structure-activity relationship homology (SARAH): a conceptual framework for drug discovery in the genomic era [J].
Frye, SV .
CHEMISTRY & BIOLOGY, 1999, 6 (01) :R3-R7
[9]  
GARRIGASUST R, UNPUB HIERARCHICAL C
[10]   Chemogenomic profiling: Identifying the functional interactions of small molecules in yeast [J].
Giaever, G ;
Flaherty, P ;
Kumm, J ;
Proctor, M ;
Nislow, C ;
Jaramillo, DF ;
Chu, AM ;
Jordan, MI ;
Arkin, AP ;
Davis, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (03) :793-798